Exheus
Company

Last deal

$671.1K
Local Amount - EUR 650.K

Amount

Pre-Seed

Stage

29.11.2022

Date

2

all rounds

$671.1K

Total amount

General

About Company
Exheus is a genetic testing technology company that uses RNA sequencing and AI to improve people's health and well-being.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2020

Number of employees

Last funding type

Pre-Seed

IPO status

Private

Description

Exheus goes beyond traditional DNA testing by analyzing RNA from a small blood sample to identify biomarkers of an individual's body parameters. This allows for the prevention of health problems and the enhancement of sports injury recovery. Exheus' technology uses AI to create a real-time optimization tool for health and nutrition, improving the quality of people's lives.
Contacts

Phone number

Social url